{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T23:08:20Z","timestamp":1756076900065,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MED-NEU\/27946\/2017"],"award-info":[{"award-number":["PTDC\/MED-NEU\/27946\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"DOI":"10.1186\/s40035-024-00412-1","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T11:02:02Z","timestamp":1712660522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pathophysiological subtypes of mild cognitive impairment due to Alzheimer\u2019s disease identified by CSF proteomics"],"prefix":"10.1186","volume":"13","author":[{"given":"Daniela","family":"Moutinho","sequence":"first","affiliation":[]},{"given":"Vera M.","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Alessandro","family":"Caula","sequence":"additional","affiliation":[]},{"given":"Sara C.","family":"Madeira","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Baldeiras","sequence":"additional","affiliation":[]},{"given":"Manuela","family":"Guerreiro","sequence":"additional","affiliation":[]},{"given":"Sandra","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"Johan","family":"Gobom","sequence":"additional","affiliation":[]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Santana","sequence":"additional","affiliation":[]},{"given":"Alexandre","family":"De Mendon\u00e7a","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Aidos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2087-4042","authenticated-orcid":false,"given":"Bruno","family":"Manadas","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"issue":"1","key":"412_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","volume":"19","author":"JA Trejo-Lopez","year":"2022","unstructured":"Trejo-Lopez JA, Yachnis AT, Prokop S. Neuropathology of Alzheimer\u2019s disease. Neurotherapeutics. 2022;19(1):173\u201385.\u00a0","journal-title":"Neurotherapeutics"},{"issue":"2","key":"412_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/10408363.2019.1670613","volume":"57","author":"KEJ Wesenhagen","year":"2020","unstructured":"Wesenhagen KEJ, Teunissen CE, Visser PJ, Tijms BM. Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer\u2019s disease: A literature review. Crit Rev Clin Lab Sci. 2020;57(2):86\u201398.\u00a0","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"12","key":"412_CR3","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1093\/brain\/awaa325","volume":"143","author":"BM Tijms","year":"2020","unstructured":"Tijms BM, Gobom J, Reus L, Jansen I, Hong S, Dobricic V, et al. Pathophysiological subtypes of Alzheimer\u2019s disease based on cerebrospinal fluid proteomics. Brain. 2020;143(12):3776\u201392.\u00a0","journal-title":"Brain"},{"issue":"1","key":"412_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-4-299","volume":"4","author":"J Maroco","year":"2011","unstructured":"Maroco J, Silva D, Rodrigues A, Guerreiro M, Santana I, De Mendon\u00e7a A. Data mining methods in the prediction of Dementia: A real-data comparison of the accuracy, sensitivity and specificity of linear discriminant analysis, logistic regression, neural networks, support vector machines, classification trees and random forests. BMC Res Notes. 2011;4(1):1\u201314.\u00a0","journal-title":"BMC Res Notes"},{"issue":"3","key":"412_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):270\u20139.\u00a0","journal-title":"Alzheimers Dement"},{"key":"412_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-1-4939-9706-0_11","volume":"2044","author":"SI Anjo","year":"2019","unstructured":"Anjo SI, Santa C, Manadas B. SWATH mass spectrometry applied to cerebrospinal fluid differential proteomics: establishment of a sample-specific method. Methods Mol Biol. 2019;2044:169\u201389.\u00a0","journal-title":"Methods Mol Biol"},{"issue":"9","key":"412_CR7","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3390\/diagnostics11091655","volume":"11","author":"CM Pedrero-Prieto","year":"2021","unstructured":"Pedrero-Prieto CM, Fronti\u00f1\u00e1n-Rubio J, Alca\u00edn FJ, Dur\u00e1n-Prado M, Peinado JR, Rabanal-Ruiz Y. Biological significance of the protein changes occurring in the cerebrospinal fluid of alzheimer\u2019s disease patients: Getting clues from proteomic studies. Diagnostics (Basel). 2021;11(9):1655.","journal-title":"Diagnostics"},{"key":"412_CR8","doi-asserted-by":"publisher","unstructured":"Ferrer-Ravent\u00f3s P, Beyer K. Alternative platelet activation pathways and their role in neurodegenerative diseases. Neurobiol Dis. 2021;159:105512. https:\/\/doi.org\/10.1016\/j.nbd.2021.105512. Epub 2021 Sep 16.","DOI":"10.1016\/j.nbd.2021.105512"},{"issue":"5","key":"412_CR9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020;26(5):769\u201380.\u00a0","journal-title":"Nat Med"},{"issue":"3","key":"412_CR10","doi-asserted-by":"publisher","first-page":"fcac134","DOI":"10.1093\/braincomms\/fcac134","volume":"4","author":"G Salvad\u00f3","year":"2022","unstructured":"Salvad\u00f3 G, Shekari M, Falcon C, Operto GDS, Mil\u00e0-Alom\u00e0 M, S\u00e1nchez-Benavides G, et al. Brain alterations in the early Alzheimer\u2019s continuum with amyloid-\u03b2, tau, glial and neurodegeneration CSF markers. Brain Commun. 2022;4(3):fcac134.\u00a0","journal-title":"Brain Commun"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-024-00412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-024-00412-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-024-00412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T11:06:04Z","timestamp":1712660764000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-024-00412-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["412"],"URL":"https:\/\/doi.org\/10.1186\/s40035-024-00412-1","relation":{},"ISSN":["2047-9158"],"issn-type":[{"type":"electronic","value":"2047-9158"}],"subject":[],"published":{"date-parts":[[2024,4,9]]},"assertion":[{"value":"29 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants were selected from the Cognitive Complaints Cohort (CCC) and recruited at Memocl\u00ednica, a private memory clinic in Lisbon, Portugal. The CCC was established in a prospective study conducted at the Faculty of Medicine, University of Lisbon, approved by the local ethics committee, conducted according to the Declaration of Helsinki and requiring the participants\u2019 informed consent [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HZ has served at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}